Literature DB >> 16213589

Oxidative DNA cleavage mediated by a new copper (II) terpyridine complex: crystal structure and DNA binding studies.

V Uma1, M Kanthimathi, T Weyhermuller, Balachandran Unni Nair.   

Abstract

The copper (II) complex [Cu(Itpy)(2)](ClO(4))(2) (1), (Itpy=imidazole terpyridine) has been synthesized and structurally characterized. Crystal structure of the complex shows the complex to be a monomeric copper (II) species with two Itpy ligands coordinated to the metal ion to give a six coordinate complex. The complex has a distorted octahedral geometry with axial elongation. Variable temperature crystal structure data shows dynamic nature of the Jahn-Teller distortion. The complex is an avid DNA binder with a binding constant of 4.26+/-0.20x10(3)M(-1). Observed changes in the viscosity and circular dichroic spectrum of calf thymus DNA solution in the presence of complex 1 suggests intercalative binding of complex 1 to DNA. The complex cleaves supercoiled pBR322 DNA oxidatively in the presence of hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213589     DOI: 10.1016/j.jinorgbio.2005.08.011

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  14 in total

1.  Rare earth complexes with 3-carbaldehyde chromone-(benzoyl) hydrazone: synthesis, characterization, DNA binding studies and antioxidant activity.

Authors:  Yong Li; Zheng-Yin Yang
Journal:  J Fluoresc       Date:  2009-10-24       Impact factor: 2.217

2.  Synthesis, characterization, antimicrobial, DNA binding and cleavage studies of mixed ligand Cu(II), Co(II) complexes.

Authors:  D Shiva Leela; B Ushaiah; G Anupama; M Sunitha; C Gyana Kumari
Journal:  J Fluoresc       Date:  2014-12-30       Impact factor: 2.217

3.  Targeting an Artificial Metal Nuclease to DNA by a Simple Chemical Modification and Its Drastic Effect on Catalysis.

Authors:  Nathalia Castilho; Philipe Gabriel; Tiago Pacheco Camargo; Ademir Neves; Hernán Terenzi
Journal:  ACS Med Chem Lett       Date:  2019-08-12       Impact factor: 4.345

4.  Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA.

Authors:  Rita Ghosh; Sudipta Bhowmik; Angshuman Bagchi; Dipankar Das; Somnath Ghosh
Journal:  Eur Biophys J       Date:  2010-02-05       Impact factor: 1.733

5.  Enhanced antitumor effect of L-buthionine sulfoximine or ionizing radiation by copper complexes with 2,2´-biquinoline and sulfonamides on A549 2D and 3D lung cancer cell models.

Authors:  J F Cadavid Vargas; C Villa Perez; D B Soria; A Guerci; A L Di Virgilio
Journal:  J Biol Inorg Chem       Date:  2022-03-05       Impact factor: 3.358

6.  Mixed Ligand Mononuclear Copper(II) Complex as a Promising Anticancer Agent: Interaction Studies with DNA/HSA, Molecular Docking, and In Vitro Cytotoxicity Studies.

Authors:  Kumudini Paliwal; Paramita Haldar; P K Sudhadevi Antharjanam; Manjuri Kumar
Journal:  ACS Omega       Date:  2022-06-13

7.  Synthesis, CMC Determination, Antimicrobial Activity and Nucleic Acid Binding of A Surfactant Copper(II) Complex Containing Phenanthroline and Alanine Schiff-Base.

Authors:  Karuppiah Nagaraj; Subramanian Sakthinathan; Sankaralingam Arunachalam
Journal:  J Fluoresc       Date:  2013-12-03       Impact factor: 2.217

8.  New Bio-Based Cu(II) Complexes and Study of their Anti-Cancer Activities.

Authors:  Rabindra Reddy Pulimamidi; Chandrashekar Ravula; Satyanarayana Battu
Journal:  J Fluoresc       Date:  2016-04-18       Impact factor: 2.217

9.  In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.

Authors:  Dharmasivam Mahendiran; Raju Senthil Kumar; Vijayan Viswanathan; Devadasan Velmurugan; Aziz Kalilur Rahiman
Journal:  J Biol Inorg Chem       Date:  2017-09-07       Impact factor: 3.358

10.  Antibacterial Activity of Co(III) Complexes with Diamine Chelate Ligands against a Broad Spectrum of Bacteria with a DNA Interaction Mechanism.

Authors:  Katarzyna Turecka; Agnieszka Chylewska; Michał Rychłowski; Joanna Zakrzewska; Krzysztof Waleron
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.